NASDAQ:AXSM

Axsome Therapeutics Earning Date

USA |NASDAQ |USD

AXSM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.95 $-0.86 $-0.58
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Axsome Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

AXSM Earnings Date & History Chart

AXSM Earnings & Revenue Forecast

AXSM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 12 $-1.03 $-1.46 $-0.86
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $-3.62 $-4.34 $-3.33
Dec 2022 14 $-3.92 $-7.36 $-2.19

AXSM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.03 $-1.02 $-1.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.62 $-3.61 $-3.80
Dec 2022 0 / 0 $-3.83 $-3.69 $-2.35

AXSM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 11 $60.00K $0.00 $630.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 15 $440.00K $0.00 $6.00M
Dec 2022 15 $44.59M $0.00 $124.98M

AXSM Earnings Date & Revenue History

AXSM Earnings History

|
Show More
Show More

AXSM Revenue History

|
Show More
Show More

Axsome Therapeutics Next Earnings Date & Report

AXSM Next Earnings Date & Report Preview: Sep 2021 (FQ)

AXSM's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 13 analysts, the average EPS estimation for Axsome Therapeutics's next quarterly earnings is $-0.95, with a low EPS estimation of $-1.22, and a high estimation of $-0.83.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.95, the last 2 month trend is $-0.95, and the 3 month trend is $-1.10.

Based on 10 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Axsome Therapeutics Previous Earnings Dates & Reports

AXSM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Axsome Therapeutics's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

AXSM's earnings per share (EPS) was $-0.86, beating the consensus analysts forecast of $-0.88 by 2.07%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 10.26%, and lower than the same period a year before (Jun 2020) by 75.51%.

Revenues were $0.00.

The company reported a net income of $-32.28M.

Free cash flow for the quarter was $-52.61M , compared to $-27.25M last quarter and $-18.90M a year before.

AXSM ended the quarter with $1.09M in total debt, a decrease of -97.81% compared to the previous quarter, and a decrease of -94.63% compared to the same quarter a year before.

AXSM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Axsome Therapeutics's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

AXSM's earnings per share (EPS) was $-2.73, beating the consensus analysts forecast of $-2.77 by -1.37% , and lower than the previous year's EPS (Dec 2019) by 36.61%.

Revenues were $0.00.

The company reported a net income of $-102.90M.

Axsome Therapeutics reported a free cash flow of $-78.50M for its fiscal year, compared to $-46.39M a year ago.

The company ended the fiscal year with $49.54M in total debt, an increase of 148.52% compared to the previous year.